Bio-Path Holdings Inc., of Houston, said it closed a registered direct offering priced at the market, generating gross proceeds of approximately $1.7 million from the sale of 648,233 shares at $2.65 each. Additionally, in a concurrent private placement, the company issued to the investors unregistered warrants to purchase up to 324,117 shares of common stock with an exercise price of $2.65 per share. It intends to use the net proceeds from the offerings for working capital and general corporate purposes.